Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

OXFORD BIOMEDICA PLC

Company number 03252665

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Aug 2024 SH01 Statement of capital following an allotment of shares on 21 August 2024
  • GBP 52,669,093.5
20 Aug 2024 SH01 Statement of capital following an allotment of shares on 16 August 2024
  • GBP 52,668,601.5
20 Aug 2024 SH01 Statement of capital following an allotment of shares on 6 August 2024
  • GBP 52,666,091
20 Aug 2024 SH01 Statement of capital following an allotment of shares on 30 July 2024
  • GBP 52,661,981.5
30 Jul 2024 AP01 Appointment of Ms. Laurence Espinasse as a director on 24 July 2024
17 Jul 2024 SH01 Statement of capital following an allotment of shares on 16 July 2024
  • GBP 52,656,885
15 Jul 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
12 Jul 2024 SH01 Statement of capital following an allotment of shares on 9 July 2024
  • GBP 52,656,069.5
12 Jul 2024 SH01 Statement of capital following an allotment of shares on 3 July 2024
  • GBP 52,654,706.5
05 Jul 2024 SH01 Statement of capital following an allotment of shares on 4 July 2024
  • GBP 52,654,350
05 Jul 2024 SH01 Statement of capital following an allotment of shares on 3 July 2024
  • GBP 52,654,047.5
05 Jul 2024 SH01 Statement of capital following an allotment of shares on 2 July 2024
  • GBP 52,653,493
05 Jul 2024 SH01 Statement of capital following an allotment of shares on 28 June 2024
  • GBP 52,652,493
04 Jul 2024 AA Group of companies' accounts made up to 31 December 2023
04 Jul 2024 TM01 Termination of appointment of Catherine Moukheibir as a director on 24 June 2024
01 Jul 2024 TM01 Termination of appointment of Michael Reuben Hayden as a director on 24 June 2024
28 Jun 2024 SH01 Statement of capital following an allotment of shares on 27 June 2024
  • GBP 52,651,895
28 Jun 2024 SH01 Statement of capital following an allotment of shares on 25 June 2024
  • GBP 52,644,712
28 Jun 2024 SH01 Statement of capital following an allotment of shares on 24 June 2024
  • GBP 52,638,130.5
25 Jun 2024 SH01 Statement of capital following an allotment of shares on 21 June 2024
  • GBP 52,636,506
24 Jun 2024 SH01 Statement of capital following an allotment of shares on 21 June 2024
  • GBP 52,634,935
19 Jun 2024 SH01 Statement of capital following an allotment of shares on 19 June 2024
  • GBP 52,634,315
17 Jun 2024 SH01 Statement of capital following an allotment of shares on 14 June 2024
  • GBP 50,033,761.5
17 Jun 2024 SH01 Statement of capital following an allotment of shares on 13 June 2024
  • GBP 50,031,222
17 Jun 2024 SH01 Statement of capital following an allotment of shares on 12 June 2024
  • GBP 50,029,547